Latest News
Eikon Therapeutics, Inc.
- Eikon Therapeutics, Inc. Estimates – BX:EIKN
- Form 8K EIKON THERAPEUTICS For: 23 October By Investing.com
- Form 8K EIKON THERAPEUTICS For: 23 October By Investing.com
- Eikon Therapeutics Presents Data from PARP1-Selective and
- Possible Turnaround For Eikon Therapeutics Insiders, Still Down US$1.4m
- Eikon Therapeutics to present seven clinical tr...
- Eikon Therapeutics Announces Seven ESMO 2026 Abstracts Highlighting Clinical Updates Across Oncology Pipeline
- Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress
- Eikon Therapeutics, Inc. Submits IND For Novel Androgen Receptor Antagonist EIK1006 In Prostate Cancer
- Eikon Therapeutics files IND for new prostate c...
- Eikon Therapeutics Inc EIKN-Q Earnings
- What Explains the 6.00% Premarket Gain for Eikon (NASDAQ:EIKN) on Before ESMO?
Headlines from the last 30 days, linking to the original publishers. See all market news →